Archive - January 2018
Mylan and Biocon win CHMP nod for Lantus biosimilar after getting beyond plant issues
Working to launch its shingles vaccine in the U.S., GlaxoSmithKline nabs Shingrix recommendation in Europe
AbbVie hikes 2018 forecast and promises shareholder rewards, thanks to U.S. tax changes
Longson trades in NICE role for position at British pharma lobby
Running Might Be The Key To Keeping Your Bones Young
FiercePharmaAsia—Takeda’s Alzheimer’s flop, Shanghai Pharma’s U.S. plan, NextCODE talk
Flu Season One of the Worst in a Decade: CDC
Lutathera Approved for Some Gastro and Pancreatic Cancers